This is the authors' abstract. We don't add key points for this paper.
OBJECTIVES: To test whether, together with platelet count, platelet activity could be an important predictor of bleeding risk in immune thrombocytopenia (ITP) patients. METHODS: Platelet activity was tested by flow cytometric measurement of agonist induced P-selectin expression and compared between 23 adult ITP patients and 22 healthy volunteers. RESULTS: Platelet activity could be either increased or decreased in ITP patients, compared to healthy volunteers. In the lowest platelet count category, normal to low platelet activity was associated with the biggest increase in bleeding risk. Risk difference 80% (95% confidence interval: 45-115%) for <32 × 10(9) platelets/L. For higher platelet counts, there was no association of platelet activity with bleeding risk. DISCUSSION: Increased platelet activity was associated with decreased bleeding risk, but only in patients with low platelet counts. CONCLUSION: Platelet activity can be a predictor of bleeding risk in ITP patients with low platelet counts.
No takes yet. Share an insight, caveat, or question.
Middelburg et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: